Despite their favorable characteristics, beta-lactam antibiotics have not been systematically applied in the treatment of tuberculosis (TB) due to the intrinsic resistance of Mycobacterium tuberculosis (Mtb) to this class, mostly credited to the potent BlaC, a chromosomally encoded and highly effective beta-lactamase (Flores et al., 2005). This evidence concerns the gene LACTB and tuberculosis.